Míriam Rosás-Umbert

Early intervention with 3BNC117 and romidepsin at antiretroviral treatment initiation in people with HIV-1: a phase 1b/2a, randomized trial

Jesper Damsgaard Gunst, Marie H. Pahus, Míriam Rosás-Umbert et al. · Nature Medicine · 2022 · 140 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +11

Administration of broadly neutralizing anti-HIV-1 antibodies at ART initiation maintains long-term CD8+ T cell immunity

Míriam Rosás-Umbert, Jesper Damsgaard Gunst, Marie H. Pahus et al. · Nature Communications · 2022 · 97 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

HIVconsv Vaccines and Romidepsin in Early-Treated HIV-1-Infected Individuals: Safety, Immunogenicity and Effect on the Viral Reservoir (Study BCN02)

Beatriz Mothe, Míriam Rosás-Umbert, Pep Coll et al. · Frontiers in Immunology · 2020 · 85 citations · Full text

Medicine, Immunology, Pharmacology +17

Impact of a TLR9 agonist and broadly neutralizing antibodies on HIV-1 persistence: the randomized phase 2a TITAN trial

Jesper Damsgaard Gunst, Jesper Falkesgaard Højen, Marie H. Pahus et al. · Nature Medicine · 2023 · 83 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Safety, immunogenicity and effect on viral rebound of HTI vaccines in early treated HIV-1 infection: a randomized, placebo-controlled phase 1 trial

Lucía Bailón, Anuska Llano, Samandhy Cedeño et al. · Nature Medicine · 2022 · 71 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16